Me is potentially selling more than just your genetic data—the personal survey info it collected is just as much a privacy ...

Explore how U.S. tariffs and vaccine skepticism may impact GSK plc's profitability. Click for my update as tariffs are ...

The U.S. Food and Drug Administration on Tuesday approved GSK's drug for a common type of urinary tract infection (UTI) in ...

GSK's consumer health spinout Haleon started trading on the London Stock Exchange this morning, making its debut with a price of 330 pence and a market valuation of around £31 billion ($37 billion).

GSK GSK stock has risen 16.9% year to date compared with an increase of 7.0% for the industry. The stock has also outperformed the sector and the S&P 500 index, as seen in the chart below.

GlaxoSmithKline would consider buying Pfizer’s consumer health business – but only if the price is right, according to the company's chief executive. Emma Walmsley has also been busy shaking ...

We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are ...

Direct-to-consumer Genetic DNA Tests Market Size and ForecastThe Direct-to-consumer (DTC) genetic DNA testing market has ...

Me, one of the first companies to provide direct-to-consumer genetic testing kits, has filed for bankruptcy. Since its ...

Me collected information from survey questions about personal health and beyond, such as drinking habits and risk tolerance.